StockCIK 818686
TEVA PHARMACEUTICAL INDUSTRIES LTD (TEVA): Insider Trades and Fund Holdings
In the past 12 months, TEVA PHARMACEUTICAL INDUSTRIES LTD insiders reported 0 open-market purchases worth $0 and 5 sales worth $15.7M; 1 of the sales were reported as made under a 10b5-1 trading plan.
0Insider buys, 12 months
$0Bought by insiders, 12 months
$15.7MSold by insiders, 12 months
2Tracked funds holding
Recent insider trades
Open-market purchases (code P) and sales (code S) from Form 4. Grants, option exercises and gifts are not shown. Latest filing: Sep 22, 2026.
| Filed | Insider | Type | Value |
|---|---|---|---|
| Sep 22 | Roberto MignoneDirector | ▼ SELL | $14.4M |
| Sep 22 | Brian SavageGeneral Counsel | ▼ SELL | $285K |
| Aug 25 | Amir WeissCAO | ▼ SELL | $355K |
| Aug 25 | Ronit Satchi-FainaroDirector | ▼ SELL | $15K |
| Aug 19 | Evan LippmanEVP | ▼ SELL10b5-1 | $680K |
Source: SEC Form 4 filings, retrieved Oct 28, 2026. How we read filings
Insiders who traded in the past year
| Insider | Role | Buys | Bought | Sells | Sold |
|---|---|---|---|---|---|
| Roberto Mignone | Director | 0 | $0 | 1 | $14.4M |
| Brian Savage | General Counsel | 0 | $0 | 1 | $285K |
| Amir Weiss | CAO | 0 | $0 | 1 | $355K |
| Ronit Satchi-Fainaro | Director | 0 | $0 | 1 | $15K |
| Evan Lippman | EVP | 0 | $0 | 1 | $680K |
ADVERTISEMENT
320 × 100 ad slot
Tracked funds that report TEVA
From each fund's latest 13F. Holdings are as of quarter end and are filed up to 45 days later.
| Fund | Shares | Value | Change |
|---|---|---|---|
| Bridgewater Associates | 1,326,678 | $44.9M | ▲ +17.6% |
| Duquesne Family Office | 624,999 | $21K | ▼ −73.7% |
Source: SEC Form 13F-HR filings, retrieved Oct 28, 2026. How we read filings
Reading these numbers
Insiders sell for many reasons: taxes, diversification, a house. Purchases with their own money are rarer and are usually read as more informative. A Form 4 is due within two business days of the trade. How to read a Form 4 →